These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8205084

  • 1. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.
    Colombat P, Donadio D, Fouillard L, Milpied N, Tilly H, Pico J, Abgrall JF, Coiffier B, Herbrecht R, Philip T.
    Bone Marrow Transplant; 1994 Feb; 13(2):157-62. PubMed ID: 8205084
    [Abstract] [Full Text] [Related]

  • 2. Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study.
    Linassier C, Fouillard L, Milpied N, Tilly H, Pico J, Abgrall JF, Coiffier B, Herbrecht R, Biron P, Colombat P.
    Cancer Detect Prev; 1996 Feb; 20(1):11-9. PubMed ID: 8907199
    [Abstract] [Full Text] [Related]

  • 3. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [Abstract] [Full Text] [Related]

  • 4. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S, Divine CL, Deauna-Limayo D, Bodensteiner DC, Cook JD, Lewis JN, Skikne BS.
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [Abstract] [Full Text] [Related]

  • 5. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
    Haas R, Moos M, Möhle R, Döhner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W.
    Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
    [Abstract] [Full Text] [Related]

  • 6. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B, Milpied N, Mellerin MP, Moreau P, Morineau N, Vigier M, Harousseau JL.
    Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
    [Abstract] [Full Text] [Related]

  • 7. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
    Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S.
    Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
    [Abstract] [Full Text] [Related]

  • 8. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
    Zhou SY, Shi YK, He XH, Han XH, Liu P, Yang JL, Zhou AP, Feng FY.
    Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
    [Abstract] [Full Text] [Related]

  • 9. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L, Lalle M, Pandolfi A, Ruscio C, Amodeo R.
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [Abstract] [Full Text] [Related]

  • 10. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
    Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS.
    J Clin Oncol; 2007 Jun 20; 25(18):2554-9. PubMed ID: 17515573
    [Abstract] [Full Text] [Related]

  • 11. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
    Stein RS, Greer JP, Goodman S, Kallianpur A, Ahmed MS, Wolff SN.
    Bone Marrow Transplant; 1999 Feb 20; 23(3):227-33. PubMed ID: 10084253
    [Abstract] [Full Text] [Related]

  • 12. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
    Wang H, Cui X, Shao Y.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 20; 23(5):436-8. PubMed ID: 11810783
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.
    Bone Marrow Transplant; 1997 Jul 20; 20(1):21-6. PubMed ID: 9232251
    [Abstract] [Full Text] [Related]

  • 14. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM, Loberiza FR, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM.
    Bone Marrow Transplant; 2001 Feb 20; 27(4):387-96. PubMed ID: 11313668
    [Abstract] [Full Text] [Related]

  • 15. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K, Margolin K, Champlin R, Forman S.
    Cancer J Sci Am; 1997 Dec 20; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [Abstract] [Full Text] [Related]

  • 16. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E, Fernández de Sevilla A, Domingo-Claros A, Romagosa V, Martín-Henao GA, De Sanjose S, Carmona M, Petit J, García J, Grañena A.
    Bone Marrow Transplant; 2000 Nov 20; 26(10):1051-6. PubMed ID: 11108302
    [Abstract] [Full Text] [Related]

  • 17. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
    Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS.
    Biol Blood Marrow Transplant; 1999 Nov 20; 5(4):262-8. PubMed ID: 10465106
    [Abstract] [Full Text] [Related]

  • 18. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
    Bone Marrow Transplant; 2002 Dec 20; 30(12):885-91. PubMed ID: 12476281
    [Abstract] [Full Text] [Related]

  • 19. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
    Schetelig J, Fetscher S, Reichle A, Berdel WE, Beguin Y, Brunet S, Caballero D, Majolino I, Hagberg H, Johnsen HE, Kimby E, Montserrat E, Stewart D, Copplestone A, Rösler W, Pavel J, Kingreen D, Siegert W.
    Haematologica; 2003 Nov 20; 88(11):1272-8. PubMed ID: 14607756
    [Abstract] [Full Text] [Related]

  • 20. Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
    Da WM, Zhong JT, Liu Y, Huang YS, Bai H, Wu XX, Ou YX, Wang CB, Xu SF.
    Chin Med J (Engl); 1993 Apr 20; 106(4):277-81. PubMed ID: 8325155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.